US EditionPublished • loading... • Updated
Algernon Closes Second Tranche of Private Placement Financing - Algernon Health (OTC:AGNPF)
Algernon raised CAD 210,000 in its latest private placement to fund the launch of its first U.S. Alzheimer’s Disease clinic and expand its neuroimaging network.
- On Nov. 28, 2025, Algernon Health Inc. closed the Second Tranche of its non-brokered private placement, raising CAD $210,000 from the sale of 3,000,000 units at CAD $0.07 per Unit.
- Proceeds will support advancing the Alzheimer’s Disease program, including opening its first U.S. AD clinic and funding general expenses, while Algernon USA LLC recently formed to oversee U.S. neuroimaging.
- The company noted that issued securities are subject to a statutory hold period of four months plus a day, are not registered under the United States Securities Act of 1933, and include forward‑looking statements and related risks.
- The financing positions Algernon Health Inc. to support its planned North American network of brain‑optimized PET scanning clinics for early‑stage detection of Alzheimer’s Disease and other neurological disorders.
- The company warned that failure to satisfy relevant securities exchange conditions and uncertainties could affect planned financings and clinic openings.
Insights by Ground AI
11 Articles
11 Articles
Algernon Closes Second Tranche of Private Placement Financing - Algernon Health (OTC:AGNPF)
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the "Company" or "Algernon") (CSE:AGN)
·New York, United States
Read Full ArticleCoverage Details
Total News Sources11
Leaning Left5Leaning Right2Center2Last UpdatedBias Distribution56% Left
Bias Distribution
- 56% of the sources lean Left
56% Left
L 56%
C 22%
R 22%
Factuality
To view factuality data please Upgrade to Premium
